NCEL
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- NewcelX received a Brazilian patent for NCEL-101 in type 1 diabetes, expanding its global intellectual property portfolioJul 16, 2026
- NewcelX reported a successful FDA pre-IND meeting, clearing the path for NCEL-101 clinical trials in type 1 diabetesJul 2, 2026
- NewcelX updated its presentation highlighting its type 1 diabetes program after strategic collaboration with Eledon PharmaceuticalsApr 20, 2026
- NewcelX announced positive results from stem cell islet delivery study in type 1 diabetesJan 12, 2026